(Q34250588)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11352181%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

Regulation of bone cell development and function: implication for renal osteodystrophy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11352181%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11352181%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

E A González

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11352181%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 May 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11352181%20AND%20SRC:MED&resulttype=core&format=json

Journal of Investigative Medicine

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11352181%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11352181%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11352181%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

240-249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11352181%20AND%20SRC:MED&resulttype=core&format=json

Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Mechanism of bone turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Identification of osteoclast-specific monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

The family of bone morphogenetic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Bone: formation by autoinduction

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Novel regulators of bone formation: molecular clones and activities

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Regulation of Smad activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Murine osteogenic protein (OP-1): High levels of mRNA in kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Purification and characterization of other distinct bone-inducing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Effects of inhibitors of signal transduction pathways on transforming growth factor beta1 and osteogenic protein-1-induced insulinlike growth factor binding protein-3 expression in human bone cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Osteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Osteoclastic bone resorption by a polarized vacuolar proton pump

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

RANK is essential for osteoclast and lymph node development

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Bone histology in incipient and advanced renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

The role of cytokines in skeletal remodelling: possible consequences for renal osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroi

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

Plasma insulin-like growth factors and bone formation in uremic hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2001.33968

21 January 2018

Identifiers

DOI

10.2310/6650.2001.33968

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11352181%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference